<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Allergy testing in eosinophilic esophagitis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Allergy testing in eosinophilic esophagitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Allergy testing in eosinophilic esophagitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott H Sicherer, MD, FAAAAI</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert A Wood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth TePas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H21496970"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Eosinophilic esophagitis (EoE) was defined by a panel of experts as "a chronic, immune/antigen-mediated, esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation" [<a href="#rid1">1</a>].<em> </em>Allergy testing in EoE is warranted to identify and manage common comorbid atopic diseases (eg, asthma, allergic rhinitis) and to determine foods that may present a risk for acute allergic reactions/immediate-type allergy when eliminated foods are reintroduced into the diet during treatment.</p><p>The evidence supporting the role of allergies in EoE and the various types of allergy testing used are reviewed here. Other aspects of disease pathogenesis, clinical manifestations, general diagnostic evaluation, and treatment (including choosing a specific elimination diet) are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/2243.html" rel="external">"Clinical manifestations and diagnosis of eosinophilic esophagitis (EoE)"</a> and  <a class="medical medical_review" href="/z/d/html/2247.html" rel="external">"Treatment of eosinophilic esophagitis (EoE)"</a> and  <a class="medical medical_review" href="/z/d/html/16606.html" rel="external">"Dietary management of eosinophilic esophagitis"</a> and  <a class="medical medical_basics" href="/z/d/html/86229.html" rel="external">"Patient education: Eosinophilic esophagitis (The Basics)"</a>.)</p><p class="headingAnchor" id="H21496977"><span class="h1">EVIDENCE FOR ROLE OF ALLERGIES IN EoE</span><span class="headingEndMark"> — </span>Several lines of evidence suggest that allergies play a significant role in EoE. An immune response to allergen/antigen is a primary factor in the pathogenesis of the disease, and there is evidence that both environmental allergies and food allergies are involved. In addition, the majority of patients with EoE are atopic, with concomitant asthma, allergic rhinitis, atopic dermatitis, and/or immunoglobulin E (IgE) mediated food allergy.</p><p class="headingAnchor" id="H17767531"><span class="h2">Mechanistic studies</span><span class="headingEndMark"> — </span>Evidence for allergies in EoE is supported by murine models that show that skin sensitization protocols can induce eosinophilic inflammation in the esophagus when that organ is challenged [<a href="#rid2">2-4</a>]. In addition, examination of esophageal samples has indicated that classic allergic T2 cytokines and chemokines (interleukin [IL] 4, IL-5, IL-13, eotaxin 3) are involved in the pathogenesis of EoE [<a href="#rid1">1,4-7</a>]. Additional details on the pathogenesis of EoE are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/90146.html" rel="external">"Eosinophilic esophagitis (EoE): Genetics and immunopathogenesis", section on 'Overview of pathogenesis'</a>.)</p><p class="headingAnchor" id="H21496991"><span class="h2">Clinical response to dietary changes</span><span class="headingEndMark"> — </span>The evidence for the role of food allergies in the pathogenesis of EoE is based upon the clinical response when patients are placed on various elimination diets, with resolution of symptoms and normalization of esophageal biopsies. The data are equally extensive and convincing in children and adults. This evidence is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/16606.html" rel="external">"Dietary management of eosinophilic esophagitis", section on 'Role of food allergy in EoE'</a>.)</p><p class="headingAnchor" id="H21496998"><span class="h2">Association with environmental allergies</span><span class="headingEndMark"> — </span>The evidence that environmental allergies are involved in EoE is more controversial than food allergies, and the precise mechanisms involved are unknown. Environmental allergies may contribute to EoE in allergic patients through the direct effect of swallowed inhaled allergens in the esophagus and/or through postnasal drainage from allergic rhinitis triggering symptomatic and histologic changes [<a href="#rid8">8</a>]. Alternatively, it may involve a regional airway response or a more systemic response with subsequent trafficking of eosinophils into the esophagus [<a href="#rid9">9,10</a>].</p><p>The diagnosis of EoE has been shown to occur in a seasonal pattern in both children and adults, with peaks of new diagnosis occurring at the height of the aeroallergen season and a decrease in newly diagnosed patients in the winter [<a href="#rid11">11-13</a>]. In one of these series, less intense esophageal eosinophilia was seen in the winter [<a href="#rid13">13</a>]. Consistent with this result, duodenal eosinophilia, mucosal IgE+ cells, and T cells were found on biopsies during the peak of birch pollen season, but not out of season, in birch-sensitive patients [<a href="#rid14">14</a>]. Up to 20 eosinophils per high power field were found in the esophagus during pollen season in a set of patients with seasonal allergies [<a href="#rid15">15</a>]. A review of patients with EoE at the author's institution found that approximately 14 percent of patients had symptoms that were worse during the pollen season [<a href="#rid8">8</a>]. Histologic changes during the peak pollen season were confirmed in 20 percent of that cohort.</p><p>One patient was reported whose EoE was solely dependent on environmental allergies, with up to 40 eosinophils per high power field in the esophagus that resolved out of pollen season [<a href="#rid16">16</a>]. We have found five more similar patients that have no food sensitization but only aeroallergen sensitization [<a href="#rid17">17</a>]. These patients tend to be older than the patients with food-dependent EoE. Consistent with this finding and similar to what is seen in children without EoE, food sensitization based upon skin testing and atopy patch testing (APT) decreased with age and aeroallergen sensitization increased with age in a cross-section of children with EoE [<a href="#rid18">18</a>].</p><p>In addition, there are case reports of the development of EoE after initiation of sublingual immunotherapy (SLIT) for environmental allergies [<a href="#rid19">19,20</a>]. However, the findings for subcutaneous immunotherapy (SCIT) are more variable, with some reporting histologic and symptomatic improvement in EoE after SCIT and other reporting exacerbations or recurrences [<a href="#rid10">10,21,22</a>].</p><p class="headingAnchor" id="H9064904"><span class="h2">Atopic history</span><span class="headingEndMark"> — </span>Multiple studies have found that 30 to 50 percent of pediatric patients with EoE have clinician-diagnosed asthma, up to 20 percent have atopic dermatitis, 50 to 75 percent have allergic rhinitis, and 60 percent have urticarial reactions or anaphylaxis to foods [<a href="#rid23">23-29</a>]. There are less data in adults, but the population appears similarly atopic, with 30 to 50 percent having asthma, 50 to 75 percent having allergic rhinitis, approximately 51 percent having food pollen allergy syndrome, and 5 to 10 percent having atopic dermatitis [<a href="#rid30">30-35</a>].</p><p class="headingAnchor" id="H21497005"><span class="h1">FOOD ALLERGY TESTING IN EoE</span><span class="headingEndMark"> — </span>Testing for IgE-mediated food allergies in patients with EoE is primarily used to identify patients who are also at risk for acute allergic reactions to foods (eg, urticaria, anaphylaxis) when the foods are reintroduced after an empiric elimination diet [<a href="#rid36">36</a>]. The clinical utility of food allergen testing for identification of EoE triggers remains largely unknown, with data concerning sensitivity and specificity derived thus far from a few centers that primarily manage children. Limited data in adolescents and adults suggest that the value of food allergy testing in EoE appears to decline with increasing age. In addition, allergy testing for foods is not solely sufficient to diagnose food triggers (response to diet and results from biopsies are needed to confirm the relationship). (See  <a class="medical medical_review" href="/z/d/html/16606.html" rel="external">"Dietary management of eosinophilic esophagitis", section on 'Reintroduction of foods'</a>.)</p><p>There are three main methods for testing food allergies in EoE: skin prick testing (SPT), in vitro specific IgE testing, and atopy patch testing (APT). SPT and in vitro testing are used to identify IgE-mediated allergies, and APT is used to identify non-IgE-mediated allergies.</p><p>A food that tests negative is probably <strong>not</strong> a trigger if the negative predictive value (NPV) for that food-specific test is high. Similarly, a food that tests positive is most likely a trigger if the positive predictive value (PPV) for that food-specific test is high. Predictive values are affected by disease prevalence. APT appears to have better NPVs than SPT (ie, the foods that test negative are probably not triggers), but PPVs are typically better with SPT than APT (ie, the foods that test positive may be triggers). Combining APT and SPT results improves NPV but worsens PPV.</p><p>Detailed discussions of skin and blood testing for allergic disease are reviewed separately. Other testing methods including basophil activation testing, lymphocyte stimulation, intradermal skin testing, and others have not been studied in EoE. (See  <a class="medical medical_review" href="/z/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease"</a> and  <a class="medical medical_review" href="/z/d/html/5540.html" rel="external">"Overview of in vitro allergy tests"</a> and  <a class="medical medical_review" href="/z/d/html/2396.html" rel="external">"Diagnostic evaluation of IgE-mediated food allergy"</a> and  <a class="medical medical_review" href="/z/d/html/2414.html" rel="external">"Future diagnostic tools for food allergy"</a>.)</p><p class="headingAnchor" id="H21497012"><span class="h2">Skin prick testing</span><span class="headingEndMark"> — </span>The predictive values of SPT to individual foods associated with resolution of symptoms and normalization of esophageal biopsies have been explored in patients with EoE. The PPVs and NPVs for 10 of the most common foods that cause EoE were determined in a pediatric population evaluated at one center [<a href="#rid37">37-39</a>]. The NPV on isolated skin testing was generally high, with a rate of greater than 90 percent for less common foods (potato, chicken, peanut, beef, pork, and corn) and 79 to 90 percent for hen's egg, wheat, and soy. However, the NPV was less than 30 percent for cow's milk. The PPVs were poor, ranging from 26 to 62 percent, with milk being the exception at 86 percent.</p><p>In a series of 20 adults who had success with the six-food (empiric) elimination diet, food triggers were identified in all patients upon reintroduction [<a href="#rid40">40</a>]. However, 13 of these patients were negative on skin testing to all foods tested, and skin testing only predicted 13 percent of causal foods in this series. In another series, six adults had sensitization to wheat that was not clinically relevant [<a href="#rid41">41</a>]. In a third series, 15 adults underwent a six-week elimination diet based upon SPT, prick-prick testing (PPT) to fresh foods, and APT [<a href="#rid42">42</a>]. Only four patients (26 percent) achieved complete remission, and one patient had clinical remission with partial histologic improvement.</p><p class="headingAnchor" id="H21497019"><span class="h2">Specific IgE testing</span><span class="headingEndMark"> — </span>There are few studies that examine the predictive values of specific IgE testing via in vitro immunoassay in EoE. For cow's milk-specific IgE, most studies have not found it to be predictive. One study of 53 patients with EoE found that specific IgE was a more sensitive marker of sensitization compared with APT and SPT, but a major limitation of this study was that it looked at sensitization, not clinically relevant allergy [<a href="#rid43">43,44</a>]. Another small study found that patients with EoE and very low milk IgE (0.10 to 1.00 int. unit/mL) were more likely to respond to milk elimination than those with negative milk IgE (&lt;0.10 int. unit/mL) or higher milk IgE (&gt;1.00 int. unit/mL) [<a href="#rid45">45</a>]. Studies examining component testing have shown no value in this tool for identification of foods causing EoE [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H3478481479"><span class="h2">Specific IgG4 testing</span><span class="headingEndMark"> — </span>The exact role of immunoglobulin G4 (IgG4), if any, in the pathogenesis of EoE and its utility in testing is not clear. Data have suggested that IgG4 is a marker of exposure, is not predictive of reaction, and, in patients with IgE-mediated allergy, is a marker for resolution of allergy. Elevated specific IgG4 to typical causal foods are found in adults and children with EoE [<a href="#rid47">47-49</a>]. One study found that detectable levels of food-specific IgG4 (≥0.10 microg/mL) were common in children regardless of whether they had EoE or IgE food sensitization [<a href="#rid49">49</a>]. However, high IgG4 titers (≥10.0 microg/mL) to several cow's milk proteins (Bos d 4, 5, and 8) and gluten were more commonly seen in children with EoE. This was particularly true in children with EoE and detectable IgE to cow's milk compared with controls regardless of sensitization status to milk. Specific IgG4 levels decrease by half on average after six to eight weeks on a milk-free diet. However, it has not been found to help in predicting what food is causing disease. (See  <a class="medical medical_review" href="/z/d/html/5745.html" rel="external">"Food allergy in children: Prevalence, natural history, and monitoring for resolution", section on 'Mechanisms'</a> and  <a class="medical medical_review" href="/z/d/html/116299.html" rel="external">"Unproven and disproven tests for food allergy", section on 'IgG food tests'</a>.)</p><p class="headingAnchor" id="H21497026"><span class="h2">Atopy patch testing</span><span class="headingEndMark"> — </span>The use of APT was initially explored for the diagnosis of food allergies in patients with atopic dermatitis and subsequently studied in patients with gastrointestinal symptoms. A general discussion of APT and its use in atopic dermatitis are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/2414.html" rel="external">"Future diagnostic tools for food allergy", section on 'Atopy patch testing'</a>.)</p><p>APT involves the application of fresh food or rehydrated food in an occlusive Finn chamber for 48 hours on a patient's back. The Finn chamber is then removed, and a reading of the reactions is done immediately after removal and 24 hours later. Reactions are read using a consensus scale from the European Task Force on Atopic Dermatitis that is based upon the findings of induration, erythema, and papules [<a href="#rid50">50</a>]. This scale is different than the scale used in contact dermatitis, which only examines induration. The main limitation in APT is the lack of standardized reagents. In addition, the studies of APT were primarily performed in patients with known disease, and, therefore, the test may not have the same predictive values for identifying food allergies in the general public. Additional issues include operator dependence, need to keep the allergens on the skin for 48 hours, and the requirement for multiple visits to have the tests placed, removed, and read.</p><p>The predictive values for APT in EoE were determined for causal foods identified after normalization of biopsies following removal of single foods or reintroduction of a food leading to an increase in eosinophils (&gt;15 per high power field) on esophageal biopsies performed at one center [<a href="#rid37">37-39,51</a>]. The predictive values for the most common causal foods were calculated in a sequential fashion, with each patient first undergoing SPT and then APT. Patients did not have APT to foods that were positive on SPT. The NPVs for APT were better than for SPT, with values &gt;90 percent for hen's egg, soy, peanut, beef, corn, chicken, potato, and pork and 87 percent for wheat. However, the NPV remained low for cow's milk at 31 percent. The PPVs were poor for most foods (12 to 51 percent), except for milk at 86 percent and egg at 61 percent in a cohort of 319 children [<a href="#rid37">37,39</a>]. Another group found poor NPVs for APT in a cohort of 23 children and young adults who followed testing-directed elimination diets [<a href="#rid52">52</a>]. However, the two groups used different testing materials and reading scales for a positive APT value (one designed for use in food allergy and the other for contact dermatitis), making it difficult to compare the study results. A lower rate of positive APT in older children compared with younger children suggests a limited value in older children and adults [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H1284612428"><span class="h1">ENVIRONMENTAL ALLERGY TESTING IN EoE</span><span class="headingEndMark"> — </span>Testing for aeroallergen sensitization is frequently warranted to address comorbid asthma and allergic rhinitis, to identify potential aeroallergen triggers of EoE (ie, seasonal exacerbations), and to consider timing of diagnostic biopsies in relation to pollen seasons. Evaluation for environmental allergies by performing standard allergy testing is indicated in all patients that have signs and/or symptoms of allergic rhinitis based upon history and physical examination. (See <a class="local">'Association with environmental allergies'</a> above.)</p><p>We perform standard environmental allergy testing for patients that have signs and/or symptoms of allergic rhinitis based upon history and physical examination. Seasonal allergies are treated with standard allergic rhinoconjunctivitis medications. We also treat patients with environmental allergies with intranasal glucocorticoids for one month prior to endoscopy and biopsy because observational data suggest that postnasal drainage from allergic rhinitis may contribute to esophageal eosinophilia [<a href="#rid8">8</a>]. Treatment with nasal glucocorticoids does not appear to directly affect esophageal eosinophilia and therefore should not mask active EoE due to food allergies. (See  <a class="medical medical_review" href="/z/d/html/7525.html" rel="external">"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7526.html" rel="external">"Pharmacotherapy of allergic rhinitis"</a>.)</p><p class="headingAnchor" id="H3758384967"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118161.html" rel="external">"Society guideline links: Eosinophilic esophagitis"</a>.)</p><p class="headingAnchor" id="H9065143"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Eosinophilic esophagitis (EoE) allergen triggers</strong> – EoE is a chronic, immune-mediated inflammatory disorder of the esophagus. Most patients with EoE have underlying atopic conditions, and food allergies play a major role in the pathogenesis of EoE. Environmental allergies may also contribute to EoE in allergic patients through the direct effect of allergens in the esophagus or through a regional or systemic response. (See <a class="local">'Introduction'</a> above and <a class="local">'Evidence for role of allergies in EoE'</a> above and  <a class="medical medical_review" href="/z/d/html/16606.html" rel="external">"Dietary management of eosinophilic esophagitis", section on 'Role of food allergy in EoE'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Allergy testing in EoE</strong> – Allergy testing in EoE is used to identify and manage common comorbid atopic diseases (eg, asthma, allergic rhinitis) and to determine foods that may present a risk for acute allergic reactions/immediate-type allergy when eliminated foods are reintroduced into the diet during treatment. The clinical utility of food allergen testing for identification of EoE triggers remains largely unknown. (See <a class="local">'Food allergy testing in EoE'</a> above and <a class="local">'Environmental allergy testing in EoE'</a> above.)</p><p></p><p class="headingAnchor" id="H1052121114"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Jonathan M Spergel, MD, PhD, FAAAAI, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128:3.</a></li><li><a class="nounderline abstract_t">Akei HS, Mishra A, Blanchard C, Rothenberg ME. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005; 129:985.</a></li><li><a class="nounderline abstract_t">Mondoulet L, Dioszeghy V, Larcher T, et al. Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS One 2012; 7:e31967.</a></li><li><a class="nounderline abstract_t">Mishra A, Wang M, Pemmaraju VR, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008; 134:204.</a></li><li><a class="nounderline abstract_t">Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 2010; 139:182.</a></li><li><a class="nounderline abstract_t">Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120:1292.</a></li><li><a class="nounderline abstract_t">Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116:536.</a></li><li><a class="nounderline abstract_t">Ram G, Lee J, Ott M, et al. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol 2015; 115:224.</a></li><li><a class="nounderline abstract_t">Reed CC, Iglesia EGA, Commins SP, Dellon ES. Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens. Ann Allergy Asthma Immunol 2019; 122:296.</a></li><li><a class="nounderline abstract_t">Robey BS, Eluri S, Reed CC, et al. Subcutaneous immunotherapy in patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 2019; 122:532.</a></li><li><a class="nounderline abstract_t">Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther 2010; 31:509.</a></li><li><a class="nounderline abstract_t">Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009; 104:828.</a></li><li><a class="nounderline abstract_t">Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol 2007; 41:451.</a></li><li><a class="nounderline abstract_t">Magnusson J, Lin XP, Dahlman-Höglund A, et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol 2003; 112:45.</a></li><li><a class="nounderline abstract_t">Onbasi K, Sin AZ, Doganavsargil B, et al. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 2005; 35:1423.</a></li><li><a class="nounderline abstract_t">Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003; 112:796.</a></li><li class="breakAll">Spergel J, University of Pennsylvania School of Medicine, 2012, personal communication.</li><li><a class="nounderline abstract_t">Sugnanam KK, Collins JT, Smith PK, et al. Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy 2007; 62:1257.</a></li><li><a class="nounderline abstract_t">Fujiwara Y, Tanaka F, Sawada A, et al. A case series of sublingual immunotherapy-induced eosinophilic esophagitis: stop or spit. Clin J Gastroenterol 2021; 14:1607.</a></li><li><a class="nounderline abstract_t">Skrabski F, Pérez-Pallisé ME, Domínguez Estirado A, et al. Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract. J Investig Allergol Clin Immunol 2022; 32:315.</a></li><li><a class="nounderline abstract_t">Wells R, Fox AT, Furman M. Recurrence of eosinophilic oesophagitis with subcutaneous grass pollen immunotherapy. BMJ Case Rep 2018; 2018.</a></li><li><a class="nounderline abstract_t">Iglesia EGA, Commins SP, Dellon ES. Complete remission of eosinophilic esophagitis with multi-aeroallergen subcutaneous immunotherapy: A case report. J Allergy Clin Immunol Pract 2021; 9:2517.</a></li><li><a class="nounderline abstract_t">Assa'ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 2007; 119:731.</a></li><li><a class="nounderline abstract_t">Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133:1342.</a></li><li><a class="nounderline abstract_t">Plaza-Martín AM, Jiménez-Feijoo R, Andaluz C, et al. Polysensitization to aeroallergens and food in eosinophilic esophagitis in a pediatric population. Allergol Immunopathol (Madr) 2007; 35:35.</a></li><li><a class="nounderline abstract_t">Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48:30.</a></li><li><a class="nounderline abstract_t">Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3:1198.</a></li><li><a class="nounderline abstract_t">Guajardo JR, Plotnick LM, Fende JM, et al. Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr 2002; 141:576.</a></li><li><a class="nounderline abstract_t">Hill DA, Dudley JW, Spergel JM. The Prevalence of Eosinophilic Esophagitis in Pediatric Patients with IgE-Mediated Food Allergy. J Allergy Clin Immunol Pract 2017; 5:369.</a></li><li><a class="nounderline abstract_t">Arora AA, Weiler CR, Katzka DA. Eosinophilic esophagitis: allergic contribution, testing, and management. Curr Gastroenterol Rep 2012; 14:206.</a></li><li><a class="nounderline abstract_t">Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2008; 6:531.</a></li><li><a class="nounderline abstract_t">Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008; 134:1316.</a></li><li><a class="nounderline abstract_t">Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2007; 56:615.</a></li><li><a class="nounderline abstract_t">Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006; 63:3.</a></li><li><a class="nounderline abstract_t">Mahdavinia M, Bishehsari F, Hayat W, et al. Association of eosinophilic esophagitis and food pollen allergy syndrome. Ann Allergy Asthma Immunol 2017; 118:116.</a></li><li><a class="nounderline abstract_t">Alsalamah M, Makhajia M, Somers G, et al. Anaphylaxis to Milk After Elimination Diet for Eosinophilic Gastrointestinal Disease. Am J Gastroenterol 2016; 111:752.</a></li><li><a class="nounderline abstract_t">Spergel JM, Brown-Whitehorn T, Beausoleil JL, et al. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol 2007; 119:509.</a></li><li><a class="nounderline abstract_t">Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002; 109:363.</a></li><li><a class="nounderline abstract_t">Spergel JM, Brown-Whitehorn TF, Cianferoni A, et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012; 130:461.</a></li><li><a class="nounderline abstract_t">Gonsalves N, Yang GY, Doerfler B, et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142:1451.</a></li><li><a class="nounderline abstract_t">Simon D, Straumann A, Wenk A, et al. Eosinophilic esophagitis in adults--no clinical relevance of wheat and rye sensitizations. Allergy 2006; 61:1480.</a></li><li><a class="nounderline abstract_t">Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, et al. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol 2012; 130:1200.</a></li><li><a class="nounderline abstract_t">Lucendo AJ, Arias A, Tenías JM, et al. Serum IgE-targeted elimination diets for treating eosinophilic esophagitis: things are not what they seem. Allergy 2014; 69:1567.</a></li><li><a class="nounderline abstract_t">Erwin EA, James HR, Gutekunst HM, et al. Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 2010; 104:496.</a></li><li><a class="nounderline abstract_t">Erwin EA, Kruszewski PG, Russo JM, et al. IgE antibodies and response to cow's milk elimination diet in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2016; 138:625.</a></li><li><a class="nounderline abstract_t">van Rhijn BD, Vlieg-Boerstra BJ, Versteeg SA, et al. Evaluation of allergen-microarray-guided dietary intervention as treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2015; 136:1095.</a></li><li><a class="nounderline abstract_t">Wright BL, Kulis M, Guo R, et al. Food-specific IgG4 is associated with eosinophilic esophagitis. J Allergy Clin Immunol 2016; 138:1190.</a></li><li><a class="nounderline abstract_t">Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology 2014; 147:602.</a></li><li><a class="nounderline abstract_t">Schuyler AJ, Wilson JM, Tripathi A, et al. Specific IgG4 antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 2018; 142:139.</a></li><li><a class="nounderline abstract_t">Heine RG, Verstege A, Mehl A, et al. Proposal for a standardized interpretation of the atopy patch test in children with atopic dermatitis and suspected food allergy. Pediatr Allergy Immunol 2006; 17:213.</a></li><li><a class="nounderline abstract_t">Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005; 95:336.</a></li><li><a class="nounderline abstract_t">Henderson CJ, Abonia JP, King EC, et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2012; 129:1570.</a></li></ol></div><div id="topicVersionRevision">Topic 16604 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21477849" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Eosinophilic esophagitis: updated consensus recommendations for children and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16143136" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22363776" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166354" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20381491" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18073124" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16453027" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26235409" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30578860" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30831258" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Subcutaneous immunotherapy in patients with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19925501" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Correlation between eosinophilic oesophagitis and aeroallergens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19240704" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17450024" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12847478" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Seasonal intestinal inflammation in patients with birch pollen allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16297137" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14564365" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pollen and eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14564365" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Pollen and eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17711545" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34536216" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A case series of sublingual immunotherapy-induced eosinophilic esophagitis: stop or spit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34661538" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29545433" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Recurrence of eosinophilic oesophagitis with subcutaneous grass pollen immunotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33609756" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Complete remission of eosinophilic esophagitis with multi-aeroallergen subcutaneous immunotherapy: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17258309" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pediatric patients with eosinophilic esophagitis: an 8-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17919504" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17338901" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Polysensitization to aeroallergens and food in eosinophilic esophagitis in a pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19172120" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : 14 years of eosinophilic esophagitis: clinical features and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16361045" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Eosinophilic esophagitis: a 10-year experience in 381 children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12378201" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28042003" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The Prevalence of Eosinophilic Esophagitis in Pediatric Patients with IgE-Mediated Food Allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22422505" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Eosinophilic esophagitis: allergic contribution, testing, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18304887" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Atopic characteristics of adult patients with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18471509" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17135307" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16377308" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27856094" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Association of eosinophilic esophagitis and food pollen allergy syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27151130" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Anaphylaxis to Milk After Elimination Diet for Eosinophilic Gastrointestinal Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17291865" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11842310" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22743304" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22391333" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17073881" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Eosinophilic esophagitis in adults--no clinical relevance of wheat and rye sensitizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22867695" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25286961" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Serum IgE-targeted elimination diets for treating eosinophilic esophagitis: things are not what they seem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20568382" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27113847" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : IgE antibodies and response to cow's milk elimination diet in pediatric eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25935104" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Evaluation of allergen-microarray-guided dietary intervention as treatment of eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27130859" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Food-specific IgG4 is associated with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24907494" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29678750" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Specific IgG4 antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16672009" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Proposal for a standardized interpretation of the atopy patch test in children with atopic dermatitis and suspected food allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16279563" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22541246" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
